JP2012508784A5 - - Google Patents

Download PDF

Info

Publication number
JP2012508784A5
JP2012508784A5 JP2011543797A JP2011543797A JP2012508784A5 JP 2012508784 A5 JP2012508784 A5 JP 2012508784A5 JP 2011543797 A JP2011543797 A JP 2011543797A JP 2011543797 A JP2011543797 A JP 2011543797A JP 2012508784 A5 JP2012508784 A5 JP 2012508784A5
Authority
JP
Japan
Prior art keywords
particulate material
material according
particulate
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011543797A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012508784A (ja
Filing date
Publication date
Priority claimed from FR0857763A external-priority patent/FR2938431B1/fr
Application filed filed Critical
Publication of JP2012508784A publication Critical patent/JP2012508784A/ja
Publication of JP2012508784A5 publication Critical patent/JP2012508784A5/ja
Pending legal-status Critical Current

Links

JP2011543797A 2008-11-14 2009-11-10 γ−ヒドロキシ酪酸に基づく新規の組成物 Pending JP2012508784A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0857763A FR2938431B1 (fr) 2008-11-14 2008-11-14 Nouvelle composition a base d'acide gamma-hydroxybutyrique
FR0857763 2008-11-14
PCT/FR2009/052169 WO2010055260A1 (fr) 2008-11-14 2009-11-10 Nouvelle composition à base d'acide gamma-hydroxybutyrique

Publications (2)

Publication Number Publication Date
JP2012508784A JP2012508784A (ja) 2012-04-12
JP2012508784A5 true JP2012508784A5 (cg-RX-API-DMAC7.html) 2016-05-26

Family

ID=40674006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011543797A Pending JP2012508784A (ja) 2008-11-14 2009-11-10 γ−ヒドロキシ酪酸に基づく新規の組成物

Country Status (34)

Country Link
US (1) US8529954B2 (cg-RX-API-DMAC7.html)
EP (1) EP2349217B1 (cg-RX-API-DMAC7.html)
JP (1) JP2012508784A (cg-RX-API-DMAC7.html)
KR (1) KR101563390B1 (cg-RX-API-DMAC7.html)
CN (2) CN102215822A (cg-RX-API-DMAC7.html)
AR (1) AR074351A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009315441B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0916021B8 (cg-RX-API-DMAC7.html)
CA (1) CA2743767C (cg-RX-API-DMAC7.html)
CL (1) CL2011001114A1 (cg-RX-API-DMAC7.html)
CO (1) CO6382106A2 (cg-RX-API-DMAC7.html)
CU (1) CU20110109A7 (cg-RX-API-DMAC7.html)
CY (1) CY1122209T1 (cg-RX-API-DMAC7.html)
DK (1) DK2349217T3 (cg-RX-API-DMAC7.html)
EA (1) EA023305B1 (cg-RX-API-DMAC7.html)
ES (1) ES2749803T3 (cg-RX-API-DMAC7.html)
FR (1) FR2938431B1 (cg-RX-API-DMAC7.html)
HR (1) HRP20191911T1 (cg-RX-API-DMAC7.html)
HU (1) HUE046321T2 (cg-RX-API-DMAC7.html)
IL (1) IL212847A (cg-RX-API-DMAC7.html)
LT (1) LT2349217T (cg-RX-API-DMAC7.html)
MA (1) MA32790B1 (cg-RX-API-DMAC7.html)
MX (1) MX2011005073A (cg-RX-API-DMAC7.html)
NZ (1) NZ592850A (cg-RX-API-DMAC7.html)
PE (1) PE20120028A1 (cg-RX-API-DMAC7.html)
PL (1) PL2349217T3 (cg-RX-API-DMAC7.html)
PT (1) PT2349217T (cg-RX-API-DMAC7.html)
SI (1) SI2349217T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201900721T1 (cg-RX-API-DMAC7.html)
TN (1) TN2011000231A1 (cg-RX-API-DMAC7.html)
TW (1) TWI446906B (cg-RX-API-DMAC7.html)
UA (1) UA103057C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010055260A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201103542B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
MX391660B (es) 2010-03-24 2025-03-21 Jazz Pharmaceuticals Inc Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas
FR2971422B1 (fr) * 2011-02-11 2016-05-20 Debregeas Et Associes Pharma Granules d'acide gamma-hydroxybutyrique
US9050302B2 (en) * 2013-03-01 2015-06-09 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11000498B2 (en) 2016-07-22 2021-05-11 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US20190183806A1 (en) * 2017-12-20 2019-06-20 Flamel Ireland Limited Packaged modified release gamma-hydroxybutyrate formulations having improved stability
BR112021006027A2 (pt) 2018-11-19 2021-06-29 Jazz Pharmaceuticals Ireland Limited formulações de fármaco resistente a álcool
BR112021013766A2 (pt) * 2019-03-01 2021-09-21 Flamel Ireland Limited Composições de gama-hidroxibutirato com farmacocinética melhorada no estado alimentado
WO2021127461A1 (en) 2019-12-20 2021-06-24 Xw Laboratories Limited Methods of synthesizing 4-valyloxybutyric acid
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
AU2021292406B2 (en) * 2020-06-18 2024-03-14 XWPharma Ltd. Controlled release granulations of water-soluble active pharmaceutical ingredients
KR102982616B1 (ko) 2020-06-18 2026-06-26 엑스더블유파마 리미티드 수용성 원료의약품의 약학적 과립화제
WO2022020621A1 (en) 2020-07-24 2022-01-27 XWPharma Ltd. Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative
AU2021357705B2 (en) * 2020-10-05 2024-09-26 XWPharma Ltd. Modified release compositions of a gamma-hydroxybutyric acid derivative
US12582622B2 (en) 2020-10-08 2026-03-24 Jazz Pharmaceuticals Ireland Limited Sodium oxybate to treat idiopathic hypersomnia
CN112868909A (zh) * 2021-01-22 2021-06-01 湖北神舟化工有限公司 一种无臭型丁酸钠及其生产方法
DK4308086T3 (da) 2021-03-19 2025-11-17 Xwpharma Ltd Farmakokinetik af formuleringer med kombineret frigivelse af et gamma-hydroxysmørsyrederivat
CN117157060A (zh) * 2021-04-16 2023-12-01 南京纽邦生物科技有限公司 包衣β-羟基丁酸晶体及其制备方法
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
CN121038779A (zh) 2023-02-03 2025-11-28 特瑞斯制药公司 每晚一次的低钠羟丁酸盐组合物
CN117413958B (zh) * 2023-12-04 2026-02-03 湖北中烟工业有限责任公司 一种加热不燃烧烟草制品发烟段物料及其制作工艺和加热不燃烧烟草制品

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4101650A (en) 1977-04-06 1978-07-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Pepstatin floating minicapsules
US4424235A (en) 1981-09-14 1984-01-03 Hoffmann-La Roche Inc. Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
IT1217783B (it) * 1988-06-03 1990-03-30 Farmaceutico Ct S R L Lab Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative
IT1248588B (it) * 1991-06-28 1995-01-19 Gaetano Crepaldi Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.
IT1266565B1 (it) * 1993-07-22 1997-01-09 Ct Lab Farm Srl Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
US6214386B1 (en) 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
US5846971A (en) 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
JP3447042B2 (ja) * 1997-07-23 2003-09-16 フロイント産業株式会社 単一物質球形粒の製造方法
GB9725219D0 (en) 1997-11-29 1998-01-28 Cleansharp Ltd Tablets
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
WO2000038672A2 (en) * 1998-12-23 2000-07-06 Orphan Medical, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
JP2002544220A (ja) * 1999-05-17 2002-12-24 デー.ベー.エフ. 植物物質を含有する顆粒及びその製造方法
FR2797185B1 (fr) 1999-08-06 2001-10-26 Galenix Dev Composition pharmaceutique flottante comprenant une phase active et une phase non active
FR2823668B1 (fr) 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
AU2002319774B2 (en) 2001-08-06 2005-04-21 Euro-Celtique S.A. Compositions and methods to prevent abuse of opioids
US7141250B2 (en) 2001-08-06 2006-11-28 Euro-Celtique S.A. Pharmaceutical formulation containing bittering agent
US20030059397A1 (en) 2001-09-17 2003-03-27 Lyn Hughes Dosage forms
FR2829933B3 (fr) 2001-09-21 2004-03-12 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
FR2829932B1 (fr) 2001-09-21 2006-11-24 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs et produit obtenu
SI1551372T1 (en) * 2002-09-20 2018-08-31 Alpharma Pharmaceuticals Llc SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
TWI350762B (en) 2004-02-12 2011-10-21 Euro Celtique Sa Particulates
US20050214371A1 (en) 2004-03-03 2005-09-29 Simona Di Capua Stable pharmaceutical composition comprising an acid labile drug
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
US8193211B2 (en) * 2004-09-30 2012-06-05 Supernus Pharmaceuticals, Inc. Controlled release compositions of gamma-hydroxybutyrate
US7241805B2 (en) 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
US20070092565A1 (en) 2005-10-25 2007-04-26 Pharmascience Inc. Gastric retention drug delivery system
US9149434B2 (en) * 2007-12-03 2015-10-06 Tomita Pharmaceutical Co., Ltd. Core particle for pharmaceutical preparation
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments

Similar Documents

Publication Publication Date Title
TWI446906B (zh) 以γ-羥基丁酸為基礎的新穎組成物
JP6068142B2 (ja) 浮遊微粒剤
JP2013501762A5 (cg-RX-API-DMAC7.html)
JP2013501717A5 (cg-RX-API-DMAC7.html)
JP2013501718A5 (cg-RX-API-DMAC7.html)
CN101987082A (zh) 固体制剂及其制备方法
JP2007509891A5 (cg-RX-API-DMAC7.html)
JP2011506587A5 (cg-RX-API-DMAC7.html)
JP2012508786A5 (cg-RX-API-DMAC7.html)
JP2017071605A5 (cg-RX-API-DMAC7.html)
JP2005112845A (ja) 二層構造を有するエディブルシート
CN102048701B (zh) 一种匹伐他汀钙肠溶缓释微丸制剂及其制备方法
WO2016088816A1 (ja) 酢酸亜鉛水和物錠及びその製造方法
JP5608681B2 (ja) 活性成分の粒状物質を製造する新規の方法、及びそれにより得られた粒状物質
JP4364869B2 (ja) 咀嚼性カプセルの製造方法
US20070184099A1 (en) Films for use as dosage forms
CN104739775A (zh) 一种新的盐酸文拉法辛缓释小丸及其制备方法
WO2009063320A3 (es) Composición farmacéutica sólida de didanosina
CN120732801A (zh) 口含制品